Fortrea Holdings (FTRE) Long-Term Deferred Tax (2022 - 2026)
Fortrea Holdings (FTRE) reported Long-Term Deferred Tax of $6.2 million for Q1 2026, up 14.81% on a YoY basis from $5.4 million in Q1 2025, and little changed quarter-over-quarter from $6.2 million in Q4 2025.
Fortrea Holdings (FTRE) Long-Term Deferred Tax (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Long-Term Deferred Tax for 5 years, with the latest figure at $6.2 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Deferred Tax rose 14.81% year-over-year to $6.2 million; the trailing twelve-month figure through Mar 2026 stood at $6.2 million (up 14.81% YoY), and the FY2025 full-year result was $6.2 million, up 19.23% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $6.2 million, roughly flat from $6.2 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $8.3 million in Q3 2025, with the low at $1.2 million in Q4 2022.
- Historically, Long-Term Deferred Tax has averaged $4.2 million across 5 years, with a median of $3.2 million in 2023.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax surged 166.67% — and 2026, when it increased 14.81%.
- Fortrea Holdings' Long-Term Deferred Tax stood at $1.2 million in 2022, then surged by 166.67% to $3.2 million in 2023, then jumped by 62.5% to $5.2 million in 2024, then grew by 19.23% to $6.2 million in 2025, then changed by 0.0% to $6.2 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $6.2 million (Q1 2026), $6.2 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.20 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 8.30 Mn |
| Jun 30, 2025 | 5.60 Mn |
| Mar 31, 2025 | 5.40 Mn |
| Dec 31, 2024 | 5.20 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Dec 31, 2023 | 3.20 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Dec 31, 2022 | 1.20 Mn |